On this episode, We discuss some contraindications, controversies, data analysis of different clinical trials of TXA, and much more! Please see links below for referenced articles in the show.
http://www.emra.org/emresident/article/critcare-alert-crash3/
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04623-5
https://emcrit.org/pulmcrit/crash3/
https://first10em.com/halt-it-trial/
https://www.thebottomline.org.uk/summaries/icm/tich-2/
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31033-X/fulltext
https://www.bmj.com/content/343/bmj.d3795
https://rebelem.com/crash-3-txa-for-ich/
On this episode, We discuss some contraindications, controversies, data analysis of different clinical trials of TXA, and much more! Please see links below for referenced articles in the show.
http://www.emra.org/emresident/article/critcare-alert-crash3/
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04623-5
https://emcrit.org/pulmcrit/crash3/
https://first10em.com/halt-it-trial/
https://www.thebottomline.org.uk/summaries/icm/tich-2/
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31033-X/fulltext
https://www.bmj.com/content/343/bmj.d3795
https://rebelem.com/crash-3-txa-for-ich/